Otofonix Encore vs Vivtone Xpure Hearing Aid

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.

The Vivtone Xpure is a behind-the-ear OTC hearing aid priced at $549, earning a B grade with a SoundScore of 3.1/5 in HearAdvisor's lab testing. This places it in the lower tier of the OTC category, ranking #57 of 65 devices tested. The Xpure demonstrates a notably uneven performance profile. Its standout strength is music streaming, scoring an excellent 4.4/5—a remarkable 2.48 points above the category average. This makes it one of the better choices for users who prioritize audio entertainment through their hearing aids. Speech in quiet performs just slightly above category average at 2.9/5, though this remains mixed in absolute terms. However, the device shows significant weaknesses in several areas. Own-voice comfort scores a low 0.8/5, falling 1.71 points below the category average—a notable concern for users sensitive to how their own voice sounds. Speech in noise at 1.2/5 sits below the category average, and feedback handling, while solid at 3.3/5, still falls 1.24 points below what typical OTC devices achieve. The Xpure improves meaningfully with professional tuning, jumping from a normalized Initial Score of 3.0/5 to a Tuned Score of 3.5/5. Shoppers prioritizing music streaming may find value here, but those seeking balanced speech performance or natural own-voice quality should consider alternatives like the Linner Nova Earbud or Nuheara IQBuds Max, which offer higher overall scores at lower prices.